Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes
Anderson, James B. ; Martin, Stephen A ; Gadomski, Anne ; Krupa, Nicole ; Mullin, Daniel J ; Cahill, Amber ; Jenkins, Paul
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
Project ECHO
buprenorphine
medication assisted treatment
medications for opioid use disorder
primary care
treatment retention rate
Community Health and Preventive Medicine
Health Services Administration
Integrative Medicine
Primary Care
Psychiatry and Psychology
Substance Abuse and Addiction
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
Background: Our rural health system sought to (1) increase the number of primary care clinicians waivered to prescribe buprenorphine for treatment of opioid use disorder (OUD) and (2) consequently increase the number of our patients receiving this treatment.
Methods: We used the Project for Extension for Community Health Outcomes (ECHO) tele-education model as an implementation strategy. We examined the number of clinicians newly waivered, the number of patients treated with buprenorphine, the relationship between clinician engagement with ECHO training and rates of buprenorphine prescribing, and treatment retention at 180 days.
Results: The number of clinicians with a waiver and number of patients treated increased during and after ECHO training. There was a moderate correlation between the number of ECHO sessions attended by a clinician and number of their buprenorphine prescriptions (r = 0.50, p = 0.01). The 180-day retention rate was 80.7%.
Conclusions: Project ECHO was highly effective for increasing access to this evidence-based treatment. The high retention rate in this rural context indicates that most patients are increasing their likelihood of favorable outcomes.
Source
Anderson JB, Martin SA, Gadomski A, Krupa N, Mullin D, Cahill A, Jenkins P. Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes. Subst Abus. 2021 Jun 4:1-9. doi: 10.1080/08897077.2021.1931633. Epub ahead of print. PMID: 34086529. Link to article on publisher's site